Related references
Note: Only part of the references are listed.Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Georg Greiner et al.
BLOOD (2021)
Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1
Jonathan J. Lyons et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Discovery, Function, and Therapeutic Targeting of Siglec-8
Bradford A. Youngblood et al.
CELLS (2021)
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry
Hanneke C. Kluin-Nelemans et al.
LEUKEMIA (2020)
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
Jakub Trizuljak et al.
ALLERGY (2020)
Omalizumab in the treatment of adult patients with mastocytosis: A systematic review
Fatma Jendoubi et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2020)
Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study)
Meike Distler et al.
DERMATOLOGY (2020)
Eosinophil and mast cell Siglecs: From biology to drug target
Jeremy A. O'Sullivan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls
Eva Knuplez et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
Mast Cell Activation When the Whole Is Greater than the Sum of Its Parts
Dilawar Khokhar et al.
MEDICAL CLINICS OF NORTH AMERICA (2020)
The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome
Joseph Butterfield et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Microarray-Based Detection of Allergen-Reactive IgE in Patients with Mastocytosis
Dubravka Smiljkovic et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)
Elevated Tryptase in EoE Is an Independent Phenomenon Associated with Extra-Esophageal Symptoms
Geeta R. Kutty et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Serum Baseline Tryptase Level as a Marker for the Severity of Anaphylaxis
Vinicius Aniceto et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management
Mariana Castells et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Maculopapular Cutaneous Mastocytosis in a Diverse Population
Arnold S. Kirshenbaum et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS
Richard Lemal et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia
Quang T Le et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
A Sulfonamide Sialoside Analogue for Targeting Siglec-8 and -F on Immune Cells
Corwin M. Nycholat et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma
Henry R. Maun et al.
CELL (2019)
AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management
Catherine R. Weiler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice
Yadong Wei et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives
Peter Valent et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study
Wolfgang R. Sperr et al.
LANCET HAEMATOLOGY (2019)
Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis
Bradford A. Youngblood et al.
JCI INSIGHT (2019)
AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice
Bradford A. Youngblood et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Why the 20%+2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome
Peter Valent et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
Hemogenic Endothelial Fate Mapping Reveals Dual Developmental Origin of Mast Cells
Rebecca Gentek et al.
IMMUNITY (2018)
Hereditary Alpha Tryptasemia Genotyping and Associated Clinical Features
Jonathan J. Lyons
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2018)
Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder
Patrizia Bonadonna et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2018)
Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells
Jeremy A. O'Sullivan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
First Identification of an Inherited TPSAB1 Quintuplication in a Patient with Clonal Mast Cell Disease
Vito Sabato et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2018)
Frontline Science: Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils
Jeremy A. O'Sullivan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Chromogranin A is not a biomarker of mastocytosis
Pahul Hanjra et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected
Patrizia Bonadonna et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
Adult Connective Tissue-Resident Mast Cells Originate from Late Erythro-Myeloid Progenitors
Zhiqing Li et al.
IMMUNITY (2018)
Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways
Anabel Gonzalez-Gil et al.
GLYCOBIOLOGY (2018)
Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations
S. Broesby-Olsen et al.
ALLERGY (2018)
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent et al.
BLOOD (2017)
Mast cell activation syndromes
Cem Akin
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series
Giovanni Orsolini et al.
CALCIFIED TISSUE INTERNATIONAL (2017)
Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future
Peter Valent et al.
CANCER RESEARCH (2017)
Lin- CD34hi CD117int/hi FcεRI+ cells in human blood constitute a rare population of mast cell progenitors
Joakim S. Dahlin et al.
BLOOD (2016)
Analytical and clinical validation of an LC-MS/MS method for urine leukotriene E4: A marker of systemic mastocytosis
Alan J. Lueke et al.
CLINICAL BIOCHEMISTRY (2016)
Siglecting the allergic response for therapeutic targeting
Bruce S. Bochner
GLYCOBIOLOGY (2016)
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology
Karin Hartmann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis
Ivan Alvarez-Twose et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number
Jonathan J. Lyons et al.
NATURE GENETICS (2016)
Expression profiling of constitutive mast cells reveals a unique identity within the immune system
Daniel F. Dwyer et al.
NATURE IMMUNOLOGY (2016)
Vibratory Urticaria Associated with a Missense Variant in ADGRE2
Steven E. Boyden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis
M. Rossini et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside
Lei Zhang et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders
R. Divekar et al.
ALLERGY (2015)
Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis
Melody C. Carter et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis
Tim Wiechers et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Molecular basis of mast cell disease
Erinn Soucie et al.
MOLECULAR IMMUNOLOGY (2015)
Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions
Benjamin D. McNeil et al.
NATURE (2015)
Clinical characteristics and risk profile of patients with elevated baseline serum tryptase
C. Fellinger et al.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2014)
Serum basal tryptase may be a good marker for predicting the risk of anaphylaxis in children with food allergy
U. M. Sahiner et al.
ALLERGY (2014)
A Clinicopathologic Study of 24 Cases of Systemic Mastocytosis Involving the Gastrointestinal Tract and Assessment of Mucosal Mast Cell Density in Irritable Bowel Syndrome and Asymptomatic Patients
Leona A. Doyle et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience
T. Gulen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Identification of KIT activating mutations in paediatric solitary mastocytoma
Deqin Ma et al.
HISTOPATHOLOGY (2014)
Drug Allergy in Mastocytosis
Patrizia Bonadonna et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2014)
Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities
Jonathan J. Lyons et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis
Sabina Berezowska et al.
MODERN PATHOLOGY (2014)
Mast Cell Activation Syndrome: Improved Identification by Combined Determinations of Serum Tryptase and 24-Hour Urine 11β-Prostaglandin2α
Anupama Ravi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
The Utility of Serum Tryptase as a Marker in Chronic Spontaneous Urticaria
Roxana Siles et al.
ACTA DERMATO-VENEREOLOGICA (2013)
State of the art paper Mastocytosis in children and adults: clinical disease heterogeneity
Magdalena Lange et al.
Archives of Medical Science (2012)
Childhood mastocytosis
Antonio Torrelo et al.
CURRENT OPINION IN PEDIATRICS (2012)
Developmental Origin and Functional Specialization of Mast Cell Subsets
Michael F. Gurish et al.
IMMUNITY (2012)
Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal
Peter Valent et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives
Peter Valent et al.
WIENER KLINISCHE WOCHENSCHRIFT (2012)
Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations
Matthew J. Hamilton et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Developmental, Malignancy-Related, and Cross-Species Analysis of Eosinophil, Mast Cell, and Basophil Siglec-8 Expression
Sherry A. Hudson et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Protease phenotype of constitutive connective tissue and of induced mucosal mast cells in mice is regulated by the tissue
Wei Xing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Factors influencing serum total tryptase concentrations in a general adult population
Arturo Gonzalez-Quintela et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Mast cell activation syndrome: Proposed diagnostic criteria
Cem Akin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Pediatric Mastocytosis Is a Clonal Disease Associated with D816V and Other Activating c-KIT Mutations
Christine Bodemer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Increased leukotriene E4 excretion in systemic mastocytosis
Joseph H. Butterfield
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2010)
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
Ken-Hong Lim et al.
BLOOD (2009)
Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology
W. R. Sperr et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2009)
Inhibition of FcεRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement
Hidenori Yokoi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset
Fanny Lanternier et al.
PLOS ONE (2008)
Mastocytosis and allergy
Matthew Greenhawt et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain:: a study of the Spanish network on mastocytosis (REMA)
D. Gonzalez de Olano et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2007)
Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria
P. Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Tryptase genetics and anaphylaxis
GH Caughey
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
c-kit mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation
H Yanagihori et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
The European competence network on mastocytosis (ECNM)
P Valent et al.
WIENER KLINISCHE WOCHENSCHRIFT (2004)
Systemic mastocytosis
C Akin et al.
ANNUAL REVIEW OF MEDICINE (2004)
Elevated basal serum tryptase and hymenoptera venom allergy:: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy
G Haeberli et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2003)
Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, mono-mac-6 cells, and human skin-derived mast cells
LB Schwartz et al.
JOURNAL OF IMMUNOLOGY (2003)
Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: Relationship to symptomatology, tryptase levels, and bone marrow pathology
K Brockow et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia
WR Sperr et al.
BLOOD (2001)
Clinical and histopathological aspects of cutaneous mastocytosis
K Wolff et al.
LEUKEMIA RESEARCH (2001)
Diagnostic criteria and classification of mastocytosis:: a consensus proposal
P Valent et al.
LEUKEMIA RESEARCH (2001)
Pediatric mastocytosis
K Hartmann et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2000)
Share Paper
